Altre lingue Treace Medical Concepts, Inc.

Azioni

TMCI

US89455T1097

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
11,27 ^USD	-1,14%		-10,70%	-11,61%

25/03	Treace Medical Concepts tratta 100.000 pazienti con la Lapiplastica per la correzione del bunione	MT
27/02	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Treace to Present at Bank of America Health Care Conference	17/04
Treace Announces First Annual National Bunion Day	16/04
Treace to Report First Quarter 2024 Financial Results	09/04
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	25/03
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone	25/03
Treace Medical Concepts: Q4 Earnings Snapshot	27/02
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	27/02
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	27/02
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance	27/02
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results	07/02
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes	02/02
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure	02/02
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	02/02
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	01/02
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	01/02
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million	08/01
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	08/01
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	08/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Treace Medical Concepts, Inc.

Azioni

TMCI

US89455T1097

Altre lingue

Filtri